DXP Enterprises heads into its May 7 Q1 results with the stock near a 52-week high — and virtually every senior insider selling into it.
The insider story here is the standout. On April 8, in a wave of co-ordinated sales, nearly the entire executive team offloaded shares at roughly $138–$139. CEO and Chairman David Little sold 22,501 shares for over $3.1 million. CFO Kent Yee sold 6,936 shares for just under $965,000. The CIO, COO, CMO, Chief Accounting Officer, and two senior VPs all sold on the same day. COO Nick Little followed with a further $808,000 in sales on April 16. In total, insiders net-sold approximately $6.7 million worth of stock over the past 90 days. That is not routine tax-planning noise — it is a broad, senior-level decision to reduce exposure at current prices.
The stock has rewarded that patience. DXPE has climbed 21% over the past month to close at $165.04, touching a new 52-week high mid-week before pulling back 3.3% on April 29. The sell-off does not break the tape — the stock is still up roughly 0.8% on the week — but the intraday reversal from a fresh high, on a day when peers also weakened, adds texture to the insider narrative. Close peers fell 4.1% on Wednesday and dropped nearly 6% on the week, suggesting sector-level pressure rather than anything stock-specific.
Options positioning reinforces the bullish lean, and that is where the story gets interesting. The put/call ratio is running near its lowest level of the year at 0.276 — more than one standard deviation below its 20-day average of 0.34 and within reach of the 52-week trough of 0.243. Call demand is clearly dominant, reflecting broad market confidence in the recent price move. This stands in direct contrast to the insider activity: the options market is leaning bullish while the people who actually run the company are systematically lightening up.
Short positioning adds little heat to the setup. Short interest is a modest 2.1% of the free float — barely moving, up just 1.6% on the week. Borrow costs, at 0.50%, ticked higher by about 29% week-on-week but remain historically low, well under 1%. Availability in the lending pool is ample. Nothing in the short data suggests a crowded short or any squeeze dynamic. The ORTEX short score of 32.8 sits almost exactly at the median for the universe, unremarkable in either direction.
On the Street, analyst coverage is thin and the most current data comes from Freedom Broker's March 2026 note, which raised its target to $154 while maintaining a Buy — already below where the stock trades today at $165. Stephens & Co. holds an Overweight but their last published target was $95, set in March 2025, which is deeply stale relative to the current price and should be discounted entirely. The stock's EPS surprise score ranks in the 72nd percentile, a decent track record of beating estimates. The dividend score of 86 is notably high for an industrial distributor, though the company does not pay a dividend — this likely reflects capital-return consistency metrics. Valuation data from the snapshot carries a stale flag and should not be read as current.
Earnings history gives the clearest warning for bulls. The last three quarterly prints each produced negative reactions: the February 2026 release dropped 10% on the day and 9% over the following week; the March 2026 release fell 1.5% on the day and 6.7% over the five days after. A stock sitting at a 52-week high, with insiders net-selling $6.7 million in the weeks before the print, and a recent pattern of post-earnings declines, sets up a clear watch-point for May 7.
What to watch: whether Q1 results are strong enough to justify a price level that has already outrun the most recent analyst targets — and whether the broad insider selling ahead of the announcement proves prescient or merely routine profit-taking.
See the live data behind this article on ORTEX.
Open DXPE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
